712517005: Ledipasvir (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Hepatitis C virus protein NS5A inhibitor\Ledipasvir (substance)
\Substance categorized by disposition\Substance with antiviral mechanism of action (substance)\Hepatitis C virus protein NS5A inhibitor\Ledipasvir (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Anti-infective agent (substance)\Substance with antiviral mechanism of action (substance)\Hepatitis C virus protein NS5A inhibitor\Ledipasvir (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2015. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3082828013 Ledipasvir (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3082829017 Ledipasvir en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

1882731000195114 ledipasvir it Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

820061000172115 lédipasvir fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Ledipasvir (substance)	Is a	Hepatitis C virus protein NS5A inhibitor	true	Inferred relationship	Some
Ledipasvir (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Hepatitis C virus protein NS5A inhibitor (disposition)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing ledipasvir and sofosbuvir (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ledipasvir (substance)	Inferred relationship	Some	2
Product containing ledipasvir and sofosbuvir in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ledipasvir (substance)	Inferred relationship	Some	2
Product containing ledipasvir (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ledipasvir (substance)	Inferred relationship	Some	1
Product containing ledipasvir in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ledipasvir (substance)	Inferred relationship	Some	1
Ledipasvir only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ledipasvir (substance)	Inferred relationship	Some	1
Ledipasvir and sofosbuvir only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ledipasvir (substance)	Inferred relationship	Some	2
Product containing only ledipasvir and sofosbuvir in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ledipasvir (substance)	Inferred relationship	Some	2
Ledipasvir only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ledipasvir (substance)	Inferred relationship	Some	1
Product containing precisely ledipasvir 90 milligram and sofosbuvir 400 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Ledipasvir (substance)	Inferred relationship	Some	2
Product containing precisely ledipasvir 90 milligram and sofosbuvir 400 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Ledipasvir (substance)	Inferred relationship	Some	2
Ledipasvir 45 mg and sofosbuvir 200 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Ledipasvir (substance)	Inferred relationship	Some	2
Ledipasvir 45 mg and sofosbuvir 200 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Ledipasvir (substance)	Inferred relationship	Some	2
Ledipasvir 33.75 mg and sofosbuvir 150 mg oral granules sachet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Ledipasvir (substance)	Inferred relationship	Some	2
Ledipasvir 33.75 mg and sofosbuvir 150 mg oral granules sachet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Ledipasvir (substance)	Inferred relationship	Some	2
Product containing precisely ledipasvir 45 milligram and sofosbuvir 200 milligram/1 sachet conventional release oral granules (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Ledipasvir (substance)	Inferred relationship	Some	2
Product containing precisely ledipasvir 45 milligram and sofosbuvir 200 milligram/1 sachet conventional release oral granules (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Ledipasvir (substance)	Inferred relationship	Some	2

This concept is not in any reference sets